BENVENUTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 896
EU - Europa 320
AS - Asia 191
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Totale 1.412
Nazione #
US - Stati Uniti d'America 888
CN - Cina 109
IT - Italia 84
DE - Germania 43
IE - Irlanda 36
SE - Svezia 34
FR - Francia 24
KR - Corea 18
PL - Polonia 18
FI - Finlandia 17
IN - India 15
JP - Giappone 15
GB - Regno Unito 13
BE - Belgio 10
VN - Vietnam 9
UA - Ucraina 8
HK - Hong Kong 7
TR - Turchia 7
CA - Canada 6
ES - Italia 5
CZ - Repubblica Ceca 4
GR - Grecia 4
HU - Ungheria 4
RO - Romania 4
SG - Singapore 4
AT - Austria 3
NL - Olanda 3
TW - Taiwan 3
AU - Australia 2
CH - Svizzera 2
DK - Danimarca 2
MX - Messico 2
AR - Argentina 1
BR - Brasile 1
IL - Israele 1
LK - Sri Lanka 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 1.412
Città #
Fairfield 130
Chandler 82
Ann Arbor 75
Houston 60
Woodbridge 52
Seattle 50
Beijing 46
Wilmington 45
Cambridge 44
Ashburn 41
Dublin 36
Redwood City 22
Pisa 20
Warsaw 18
Nyköping 16
Torino 16
Dearborn 14
Shanghai 11
La Jolla 10
Brussels 9
Jacksonville 9
Medford 9
Princeton 9
Dong Ket 8
Guangzhou 7
Villeurbanne 7
Fremont 6
San Diego 5
Turin 5
Boston 4
Hangzhou 4
Milan 4
Pavia 4
Silver Spring 4
Tokyo 4
Bangalore 3
Barcelona 3
Boardman 3
Budapest 3
Camden 3
Chengdu 3
Chicago 3
Fontenay-sous-bois 3
Hefei 3
Hyderabad 3
Lille 3
Montréal 3
Nanchang 3
Nanjing 3
Norwalk 3
Phoenix 3
Pune 3
Seoul 3
Vienna 3
Wuhan 3
Ankara 2
Buffalo 2
Carlsbad 2
Cluj-napoca 2
Dallas 2
Edemissen 2
Florence 2
Hebei 2
Hereford 2
Irvine 2
Kobe 2
Noisy-le-grand 2
Padova 2
San Francisco 2
Sant'Agata Li Battiati 2
Taunton 2
Toronto 2
Toulouse 2
Varese 2
Xiamen 2
Aarhus 1
Alberton 1
Amsterdam 1
Andover 1
Asheboro 1
Aspendale 1
Atlanta 1
Bar Harbor 1
Barceloneta 1
Berlin 1
Bethesda 1
Bilbao 1
Bologna 1
Brno 1
Bucharest 1
Carrara 1
Chennai 1
Cheongju-si 1
Cleveland 1
Copenhagen 1
Coyoacán 1
Dahlonega 1
Delhi 1
Desio 1
Diyarbakir 1
Totale 1.011
Nome #
MET mutations in cancers of unknown primary origin (CUPs). 423
Targeting the MET oncogene in cancer and metastases. 216
Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis 188
Ron kinase transphosphorylation sustains MET oncogene addiction 166
Anti-EGFR Antibody Therapy Based on an Increased Copy Number of the EGFR Gene in Tumor Tissues 119
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report 107
An 'in-cell trial' to assess the efficacy of a monovalent anti-MET antibody as monotherapy and in association with standard cytotoxics. 93
The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells. 70
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 60
Real-world histopathological approach to malignancy of undefined primary origin (MUO) to diagnose cancers of unknown primary (CUPs) 13
Totale 1.455
Categoria #
all - tutte 3.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019125 0 0 0 0 0 0 0 0 2 18 62 43
2019/2020313 19 15 22 55 26 49 37 28 26 19 7 10
2020/2021178 9 16 7 17 19 13 18 8 18 12 11 30
2021/2022245 27 22 34 22 10 15 8 11 9 15 41 31
2022/2023229 17 23 15 26 15 39 24 11 26 2 14 17
2023/2024101 18 22 7 13 12 14 7 6 2 0 0 0
Totale 1.455